Renaissance IPO ETF logo

Renaissance IPO ETF (IPO)

Market Open
26 Oct, 05:38 PM
ARCA ARCA
$
48. 66
+0.3
+0.6203%
$
171.81M Market Cap
0.03% Div Yield
12,259 Volume
$ 48.36
Previous Close
Investors:
Add Transaction
Day Range
47.83 48.97
Year Range
39.31 60.33
Want to track IPO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

IPO trading today higher at $48.66, an increase of 0.6203% from yesterday's close, completing a monthly decrease of -7.2259% or -$3.79. Over the past 12 months, IPO stock gained 5.2108%.
IPO pays dividends to its shareholders, with the most recent payment made on Jun 22, 2026. The next estimated payment will be in 1 month ago on Sep 22, 2026 for a total of $0.0306.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on ARCA (USD).

IPO Chart

IP Group cheers investor interest in spin-outs, calls for more supportive Govt backing

IP Group cheers investor interest in spin-outs, calls for more supportive Govt backing

UK university spinouts attracted £1.56 billion of investment in the first half of 2026, but funding for new ventures collapsed by more than two-thirds, according to research published by IP Group PLC (LSE:IPO) and its fund management subsidiary Parkwalk. Investment climbed 38.2% from the second half of 2025 to its second-highest half-year level in a decade, approaching the £1.58 billion record set in 2021.

Proactiveinvestors | 4 days ago
IP Group invests £4m as Microbiotica raises £36m for clinical trials

IP Group invests £4m as Microbiotica raises £36m for clinical trials

IP Group PLC (LSE:IPO) has invested £4 million in a £36 million funding round for portfolio company Microbiotica, backing the development of a potential new treatment for ulcerative colitis. The Series C financing, led by British Business Bank, will support the progression of Microbiotica's lead drug candidate, MB310, into Phase 2 clinical trials following encouraging early-stage results.

Proactiveinvestors | 1 week ago
IP Group leads funding round for University of Liverpool AI spin-out Matter Machine

IP Group leads funding round for University of Liverpool AI spin-out Matter Machine

IP Group PLC (LSE:IPO) has led a £4 million funding round in Matter Machine, a University of Liverpool spin-out using artificial intelligence to accelerate the discovery of new materials. The oversubscribed pre-Series A financing also attracted backing from Northern Gritstone, Norrsken Evolve, LYVA Labs and other investors, with proceeds earmarked for expanding the company's team, developing its technology and building commercial partnerships.

Proactiveinvestors | 2 weeks ago

Renaissance IPO ETF Investors

Name Quantity Cost Value Profit ($) Gain (%)
Kyle P. Smith
Kyle P. Smith NewEdge Wealth LLC
6,450 $363,457.5 $313,695.75 -$49,761.75 -13.69%
Richard Slavik
Richard Slavik Newbridge Financial Services Group Inc.
1,000 $41,880 $48,530 $6,650 15.88%
Sima Elimelech
Sima Elimelech Activest Wealth Management
45 $1,884.6 $2,168.55 $283.95 15.07%
Joel A. Schreiber
Joel A. Schreiber SFI Advisors LLC
20,468 $743,664.89 $988,502.06 $244,837.17 32.92%
Richard A. Flora
Richard A. Flora Key Client Fiduciary Advisors LLC
3,954 $222,457.28 $192,737.73 -$29,719.55 -13.36%

Renaissance IPO ETF (IPO) FAQ

What is the stock price today?

The current price is $48.66.

On which exchange is it traded?

Renaissance IPO ETF is listed on ARCA.

What is its stock symbol?

The ticker symbol is IPO.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.03%.

What is its market cap?

As of today, the market cap is 171.81M.

Has Renaissance IPO ETF ever had a stock split?

No, there has never been a stock split.

Renaissance IPO ETF Profile

ARCA Exchange
US Country

Overview

This fund is designed to mirror the performance, before fees and expenses, of a specific index that tracks companies recently having completed an IPO and are listed on a U.S. exchange. By aiming to closely follow the price and yield performance of the index, the fund represents a focused investment strategy, targeting a specific portion of the market. This strategy involves investing at least 80% of its total assets in securities that are part of the index. It is important to note that the fund is non-diversified, meaning it may invest a larger portion of its assets in fewer securities, potentially increasing volatility and risk.

Products and Services

The primary offering of this fund includes:

  • Replication of Index Performance - The fund's main objective is to replicate the performance of its underlying index, which consists of U.S.-listed companies that have recently completed an IPO. This involves matching the price and yield performance of the index as closely as possible, before accounting for fees and expenses.
  • Investment in IPO Companies - By focusing on companies that have recently undergone an IPO, the fund provides investors with the opportunity to participate in the potential growth of these new market entrants. This investment approach is encapsulated by the fund's policy to invest at least 80% of its total assets in the securities making up the index.
  • Non-Diversified Portfolio - Unlike diversified funds, this fund invests in a more concentrated portfolio of securities. This means that it does not spread its investments across a wide range of securities in an effort to minimize risk. Instead, the fund focuses on a narrower range of investments, which can lead to higher volatility and risk, but also the potential for higher returns.

Contact Information

Address: Three Greenwich Office Park
Phone: 1-866-486-6476